BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Diagnosis
24 results:

  • 1. Diagnostic accuracy of qualitative and quantitative magnetic resonance imaging-guided contrast-enhanced ultrasound (MRI-guided CEUS) for the detection of prostate cancer: a prospective and multicenter study.
    Liu Y; Lu D; Xu G; Wang S; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H
    Radiol Med; 2024 Apr; 129(4):585-597. PubMed ID: 38512615
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for Breast and prostate cancer: An Episode-Based Analysis From 2015 to 2019.
    Patel TA; Jain B; Vapiwala N; Chino F; Tringale KR; Mahal BA; Yamoah K; McBride SN; Lam MB; Hubbard A; Nguyen PL; Dee EC
    Int J Radiat Oncol Biol Phys; 2024 May; 119(1):17-22. PubMed ID: 38072324
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Germline Genetic Testing After cancer diagnosis.
    Kurian AW; Abrahamse P; Furgal A; Ward KC; Hamilton AS; Hodan R; Tocco R; Liu L; Berek JS; Hoang L; Yussuf A; Susswein L; Esplin ED; Slavin TP; Gomez SL; Hofer TP; Katz SJ
    JAMA; 2023 Jul; 330(1):43-51. PubMed ID: 37276540
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Unilateral Pelvic Lymph Node Dissection in prostate cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma.
    Martini A; Wever L; Soeterik TFW; Rakauskas A; Fankhauser CD; Grogg JB; Checcucci E; Amparore D; Haiquel L; Rodriguez-Sanchez L; Ploussard G; Qiang P; Affentranger A; Marquis A; Marra G; Ettala O; Zattoni F; Falagario UG; De Angelis M; Kesch C; Apfelbeck M; Al-Hammouri T; Kretschmer A; Kasivisvanathan V; Preisser F; Lefebvre E; Olivier J; Radtke JP; Briganti A; Montorsi F; Carrieri G; Moro FD; Boström P; Jambor I; Gontero P; Chiu PK; John H; Macek P; Porpiglia F; Hermanns T; van den Bergh RCN; van Basten JA; Gandaglia G; Valerio M
    J Urol; 2023 Jul; 210(1):117-127. PubMed ID: 37052480
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparison between biparametric and multiparametric MRI diagnosis strategy for prostate cancer in the peripheral zone using PI-RADS version 2.1.
    Zhang J; Xu L; Zhang G; Zhang X; Bai X; Ji Z; Xiao Y; Sun H; Jin Z
    Abdom Radiol (NY); 2022 Aug; 47(8):2905-2916. PubMed ID: 35622121
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for prostate cancer Treatment.
    Wallach JD; Deng Y; McCoy RG; Dhruva SS; Herrin J; Berkowitz A; Polley EC; Quinto K; Gandotra C; Crown W; Noseworthy P; Yao X; Shah ND; Ross JS; Lyon TD
    JAMA Netw Open; 2021 Oct; 4(10):e2130587. PubMed ID: 34677594
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer.
    Shore R; Yu J; Ye W; Lagergren J; Rutegård M; Akre O; Stattin P; Lindblad M
    Sci Rep; 2021 Jun; 11(1):13486. PubMed ID: 34188067
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Healthcare services expenditures among prostate cancer patients with and without mood disorders in the United States: A propensity score-matched cross-sectional study.
    Alsultan MM; Hincapie AL; Schwartz R; Guo JJ
    J Psychosoc Oncol; 2021; 39(2):204-218. PubMed ID: 33280542
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Racial disparities in mortality for patients with prostate cancer after radical prostatectomy.
    Wen W; Luckenbaugh AN; Bayley CE; Penson DF; Shu XO
    Cancer; 2021 May; 127(9):1517-1528. PubMed ID: 32895938
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non-small cell lung cancer.
    Aghdam N; McGunigal M; Wang H; Repka MC; Mete M; Fernandez S; Dash C; Al-Refaie WB; Unger KR
    Cancer Med; 2020 Aug; 9(15):5362-5380. PubMed ID: 32511873
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The association of family history of prostate cancer with the diagnosis of clinically significant prostate cancer in Korean population.
    Park JS; Koo KC; Chung BH; Lee KS
    Investig Clin Urol; 2019 Nov; 60(6):442-446. PubMed ID: 31692911
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Survival Among Men at High Risk of Disseminated prostate cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation Therapy.
    Sooriakumaran P; Nyberg T; Akre O; Widmark A; Hamdy F; Graefen M; Carlsson S; Steineck G; Wiklund NP
    Eur Urol; 2017 Sep; 72(3):345-351. PubMed ID: 28416350
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patients.
    Diels J; Hamberg P; Ford D; Price PW; Spencer M; Dass RN
    Qual Life Res; 2015 Mar; 24(3):591-8. PubMed ID: 25326871
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Statins increase the risk of prostate cancer: a population-based case-control study.
    Chang CC; Ho SC; Chiu HF; Yang CY
    Prostate; 2011 Dec; 71(16):1818-24. PubMed ID: 21480313
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.
    Rigau M; Morote J; Mir MC; Ballesteros C; Ortega I; Sanchez A; Colás E; Garcia M; Ruiz A; Abal M; Planas J; Reventós J; Doll A
    Prostate; 2010 Dec; 70(16):1760-7. PubMed ID: 20672322
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.
    Sierra Díaz E; Sánchez Corona J; Rosales Gómez RC; Gutierrez Rubio SA; Vázquez Camacho JG; Solano Moreno H; Morán Moguel MC
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):241-6. PubMed ID: 20026870
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults.
    Lanoy E; Costagliola D; Engels EA
    Int J Cancer; 2010 Apr; 126(7):1724-31. PubMed ID: 19810102
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. prostate cancer and prostate-specific antigen testing in New South Wales.
    Smith DP; Supramaniam R; Marshall VR; Armstrong BK
    Med J Aust; 2008 Sep; 189(6):315-8. PubMed ID: 18803534
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. diagnosis of advanced cancer among elderly Medicare and Medicaid patients.
    Bradley CJ; Given CW; Dahman B; Luo Z; Virnig BA
    Med Care; 2007 May; 45(5):410-9. PubMed ID: 17446827
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical usefulness of circulating tumor markers].
    Ohkura H
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1131-4. PubMed ID: 15272600
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.